Want to see AU:OSS full AI Analyst Report?
OSS Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.02
Previous CloseN/A
VolumeN/A
Average Volume (3M)242.14K
Market Cap
AU$3.77M
Enterprise ValueAU$3.81
Total Cash (Recent Filing)AU$259.88K
Total Debt (Recent Filing)AU$555.74K
Price to Earnings (P/E)―
Beta-0.48
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding235,350,170
10 Day Avg. Volume271,480
30 Day Avg. Volume242,136
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-3.09
Price to Sales (P/S)0.78
P/FCF Ratio-1.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe sharp FY2026 revenue rebound indicates materially improved commercial traction and a larger operating base. If retained, this growth can improve operating leverage and support future margin recovery, although the increase started from a very low prior-year level.
Improved Earnings TrendPositive EPS growth provides evidence that per-share earnings performance improved over the measured period. Sustaining that direction could strengthen investor support and help the company progress toward profitability, though current financial results still show substantial losses.
Expanded Asset BaseThe larger asset base suggests the company expanded its underlying resources alongside the revenue rebound. Greater assets may provide additional capacity to support operations and commercial development, although their benefit depends on whether the business can convert them into profitable and internally funded growth.
Bears Say
Persistent UnprofitabilityNegative gross profit and a roughly -52% net margin show that current revenue is not covering the economics of the business. Without a durable improvement in pricing, costs, or product mix, continued losses could offset the benefits of revenue growth and prolong dependence on outside capital.
Negative Shareholders’ EquityNegative equity indicates that accumulated obligations exceed the recorded shareholder capital base, weakening financial resilience. This limits balance-sheet flexibility, increases recapitalization risk if losses continue, and can constrain the company’s ability to fund expansion without further external support.
Ongoing Cash BurnSustained negative operating and free cash flow means the business is not yet self-funding its operations or growth. Continued cash burn can consume available resources, increase financing needs, and leave the company more exposed if external funding becomes less available or more costly.
OSS FAQ
What was Stemcell United Ltd.’s price range in the past 12 months?
Stemcell United Ltd. lowest share price was AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Stemcell United Ltd.’s market cap?
Stemcell United Ltd.’s market cap is AU$3.77M.
When is Stemcell United Ltd.’s upcoming earnings report date?
Stemcell United Ltd.’s upcoming earnings report date is Mar 04, 2027 which is in 152 days.
How were Stemcell United Ltd.’s earnings last quarter?
Stemcell United Ltd. released its earnings results on Aug 31, 2026. The company reported -AU$0.002 earnings per share for the quarter.
Is Stemcell United Ltd. overvalued?
According to Wall Street analysts Stemcell United Ltd.’s price is currently Overvalued.
Does Stemcell United Ltd. pay dividends?
Stemcell United Ltd. does not currently pay dividends.
What is Stemcell United Ltd.’s EPS estimate?
Stemcell United Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stemcell United Ltd. have?
Stemcell United Ltd. has 235,350,170 shares outstanding.
What happened to Stemcell United Ltd.’s price movement after its last earnings report?
Stemcell United Ltd. reported an EPS of -AU$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Stemcell United Ltd.?
Currently, no hedge funds are holding shares in AU:OSS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Stemcell United Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
166.10%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Stemcell United Ltd.
BPH Global Ltd, along with its associated entities, specializes in the procurement, production, promotion, and sale of traditional medicinal items. Its operational reach spans Australia, Singapore, China, and the broader Southeast Asian market. The company's diverse product range features both unprocessed and refined bird's nest offerings, alongside marine botanicals like Caulerpa Lentillifera (sea grapes) and various seaweeds. These products are utilized across multiple industries, including food, nutrition, healthcare, dietary supplements, cosmetics, and personal care. Headquartered in Melbourne, Australia, the company was founded in 1984 and transitioned to its current name, BPH Global Ltd, in June 2023, having previously been known as Stemcell United Limited.
Technical Analysis
Cynata Therapeutics Limited
―
Living Cell Technologies
―
Mesoblast Limited
―
Orthocell Ltd
―
Regeneus Ltd.
―